Join to View Full Profile
1876 E Sabin DrSte 10Casa Grande, AZ 85122
Phone+1 520-836-9800
Dr. Arce-Lara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2007
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2004 - 2005
Mercy Catholic Medical CenterResidency, Internal Medicine, 2001 - 2004
Universidad de Ciencias MedicasClass of 1999
Certifications & Licensure
AZ State Medical License 2018 - 2026
WI State Medical License 2012 - 2019
TX State Medical License 2008 - 2014
OH State Medical License 2005 - 2009
KY State Medical License 2004 - 2006
PA State Medical License 2001 - 2004
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma Start of enrollment: 2014 Mar 01
- Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC Start of enrollment: 2017 Oct 17
Roles: Contact
Publications & Presentations
PubMed
- 23 citationsAllogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial.Richard F. Ambinder, Juan Wu, Brent R. Logan, Christine M. Durand, Ryan K. Shields
Biology of Blood and Marrow Transplantation. 2019-11-01 - 12 citationsPhase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma.Binod Dhakal, Anita D'Souza, Mehdi Hamadani, Carlos Arce-Lara, Katrina Schroeder
Blood Cancer Journal. 2019-07-29 - 20 citationsA Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative ...Parameswaran Hari, Omar S. Aljitawi, Carlos Arce-Lara, Rajneesh Nath, Natalie S. Callander
Biology of Blood and Marrow Transplantation. 2015-12-01
Press Mentions
Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh ShahJanuary 2nd, 2025- Breast Cancer Diagnosis? Ask These 5 QuestionsNovember 16th, 2024
- American Oncology Network Launches New Cancer FoundationNovember 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
